Replication of CLU, CR1, and PICALM Associations With Alzheimer Disease

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. L., & Stadlan, E. (2011) · Neurology · doi:10.1212/01.wnl.0000400650.92875.cf · Cited by 9,882

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429

Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease

Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786

Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857

Role of Genes and Environments for Explaining Alzheimer Disease

Gatz, M., Reynolds, C. A., Fratiglioni, L., Johansson, B., Mortimer, J. A., Berg, S., Fiske, A., & Pedersen, N. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.168 · Cited by 1,798

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1943 · Cited by 1,167

Genetic variation in Clusterin gene and Alzheimer's disease risk in Han Chinese

Yu, J., Ma, X., Wang, Y., Sun, L., Tan, L., Hu, N., & Tan, L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.01.010 · Cited by 34

Plasma Aβ 42 as a Biomarker of Prodromal Alzheimer’s Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study

Albani, D., Marizzoni, M., Ferrari, C., Fusco, F., Boeri, L., Raimondi, I., Jovicich, J., Babiloni, C., Soricelli, A., Lizio, R., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180321 · Cited by 31

Association study of susceptibility genes for late-onset Alzheimer’s disease in the Japanese population

Ohara, T., Ninomiya, T., Hirakawa, Y., Ashikawa, K., Monji, A., Kiyohara, Y., Kanba, S., & Kubo, M. (2012) · Psychiatric Genetics · doi:10.1097/ypg.0b013e3283586215 · Cited by 32

Microarray Analysis on Human Neuroblastoma Cells Exposed to Aluminum, β1–42-Amyloid or the β1–42-Amyloid Aluminum Complex

Gatta, V., Drago, D., Fincati, K., Valenti, M. T., Carbonare, L. D., Sensi, S. L., & Zatta, P. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015965 · Cited by 31

A combined effect of two Alzheimer's risk genes on medial temporal activity during executive attention in young adults

Green, A. E., Gray, J. R., DeYoung, C. G., Mhyre, T. R., Padilla, R. M., DiBattista, A. M., & Rebeck, G. W. (2014) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2013.12.020 · Cited by 32

CR1, ABCA7, and APOE genes affect the features of cognitive impairment in Alzheimer's disease

Chung, S. J., Kim, M., Kim, Y. J., Kim, J., You, S., Jang, E. H., Kim, S. Y., & Lee, J. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.01.029 · Cited by 32

Alzheimer′s Disease Genes Are Associated with Measures of Cognitive Ageing in the Lothian Birth Cohorts of 1921 and 1936

Hamilton, G., Harris, S. E., Davies, G., Liewald, D. C. M., Tenesa, A., Starr, J. M., Porteous, D. J., & Deary, I. J. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/505984 · Cited by 29

Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier

Kisler, K., Sagare, A. P., Lazić, D., Bazzi, S. A., Lawson, E. J., Hsu, C.-J., Wang, Y., Ramanathan, A., Nelson, A. R., Zhao, Z., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00597-5 · Cited by 29

ZCWPW1 is associated with late-onset Alzheimer's disease in Han Chinese: a replication study and meta-analyses

Gao, Y., Tan, M., Wang, H.-F., Zhang, W., Wang, Z., Jiang, T., Yu, J., & Tan, L. (2016) · Oncotarget · doi:10.18632/oncotarget.7945 · Cited by 30

Effect of PICALM rs3851179 polymorphism on the default mode network function in mild cognitive impairment

Sun, D.-M., Chen, H., Zuo, Q.-L., Su, F., Bai, F., & Liu, C. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.05.043 · Cited by 27

Using CSF biomarkers to replicate genetic associations in Alzheimer's disease

Schott, J. M. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.008 · Cited by 27

Defects of Nutrient Signaling and Autophagy in Neurodegeneration

Ondaro, J., Hernández-Eguiazu, H., Garciandia-Arcelus, M., Loera‐Valencia, R., Rodríguez-Gómez, L., Jiménez-Zúñiga, A., Goikolea, J., Rodriguez‐Rodriguez, P., Ruiz‐Martínez, J., Moreno, F., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.836196 · Cited by 28

Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts

Initiative, A. D. N., Zhu, X., Wang, H.-F., Jiang, T., Lu, H., Tan, M., Tan, C., Tan, L., Tan, L., & Yu, J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9638-8 · Cited by 26

Complement receptor 1 coding variant p.Ser1610Thr in Alzheimer's disease and related endophenotypes

Cauwenberghe, C. V., Bettens, K., Engelborghs, S., Vandenbulcke, M., Dongen, J. V., Vermeulen, S., Vandenberghe, R. R., Deyn, P. P. D., Broeckhoven, C. V., & Sleegers, K. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.03.008 · Cited by 26

The Association Between Clusterin and APOE Polymorphisms and Late-Onset Alzheimer Disease in a Turkish Cohort

Alaylıoğlu, M., Gezen‐Ak, D., Dursun, E., Bılgıç, B., Hanagasi, H. A., Ertan, T., Gurvit, H. I., Emre, M., Eker, E., Uysal, Ö., et al. (2016) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988716640373 · Cited by 25

Oestrogen receptor polymorphisms are an associated risk factor for mild cognitive impairment and Alzheimer disease in women APOE ɛ4 carriers: a case–control study

Martínez, M. F., Martín, X. E., Martín, E. B., Alcelay, L. G., Serrano, I. U., Busto, F. G., Álvarez-Álvarez, M., Salazar, A. M., Gandarias, R. B., Borda, S. I., et al. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003200 · Cited by 25

Clathrin, adaptors and disease: Insights from the yeast Saccharomyces cerevisiae

Payne, G. S. (2013) · Frontiers in bioscience · doi:10.2741/4149 · Cited by 26

Association between CLU gene rs11136000 polymorphism and Alzheimer’s disease: an updated meta-analysis

Zhu, R., Liu, X., & He, Z. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3259-8 · Cited by 24

Complement as a powerful “influencer” in the brain during development, adulthood and neurological disorders

Petrisko, T. J., Gómez-Arboledas, Á., & Tenner, A. J. (2021) · Advances in immunology · doi:10.1016/bs.ai.2021.09.003 · Cited by 23

Multilocus genetic profiling to empower drug trials and predict brain atrophy

Omid Kohannim, A., Hua, X., Rajagopalan, P., Hibar, D. P., Jahanshad, N., Grill, J. D., Apostolova, L. G., Toga, A. W., Jack, C. R., Weiner, M. W., et al. (2013) · NeuroImage Clinical · doi:10.1016/j.nicl.2013.05.007 · Cited by 24

Missense variants in CR1 are associated with increased risk of Alzheimer' disease in Han Chinese

Ma, X., Yu, J., Tan, M., Sun, F.-R., Miao, D., & Tan, L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.009 · Cited by 24

Two Alzheimer’s disease risk genes increase entorhinal cortex volume in young adults

DiBattista, A. M., Stevens, B. W., Rebeck, G. W., & Green, A. E. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00779 · Cited by 23

Identification and Confirmation of an Exonic Splicing Enhancer Variation in Exon 5 of the Alzheimer Disease Associated PICALM Gene

Schnetz‐Boutaud, N. C., Hoffman, J., Coe, J., Murdock, D. G., Pericak‐Vance, M. A., & Haines, J. L. (2012) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2012.00727.x · Cited by 23

Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer’s Disease

Seripa, D., Panza, F., Paroni, G., D’Onofrio, G., Bisceglia, P., Gravina, C., Urbano, M., Lozupone, M., Solfrizzi, V., Bizzarro, A., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0547-x · Cited by 21

Analyzing 74,248 Samples Confirms the Association Between CLU rs11136000 Polymorphism and Alzheimer’s Disease in Caucasian But Not Chinese population

Han, Z., Qu, J., Zhao, J., & Zou, X. (2018) · Scientific Reports · doi:10.1038/s41598-018-29450-2 · Cited by 22

Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer’s Disease

Nelson, A. R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.858429 · Cited by 24

The "Alzheimer's disease signature": potential perspectives for novel biomarkers

Davinelli, S., Intrieri, M., Russo, C., Costanzo, A. D., Zella, D., Bosco, P., & Scapagnini, G. (2011) · Immunity & Ageing · doi:10.1186/1742-4933-8-7 · Cited by 22

Lessons from genome‐wide association studies findings in Alzheimer's disease

Moraes, C. F., Lins, T. C. D. L., CARMARGOS, E. F., Naves, J. O. S., Pereira, R. W., & Nóbrega, O. D. T. (2011) · Psychogeriatrics · doi:10.1111/j.1479-8301.2011.00378.x · Cited by 19

Impacts of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in alzheimer’s disease

Zhu, X., Dai, W.-Z., & Ma, T. (2020) · BMC Medical Genetics · doi:10.1186/s12881-020-01114-x · Cited by 20

Genetic association of complement receptor 1 polymorphism rs3818361 in Alzheimer's disease

Antúnez, C., Boada, M., López‐Arrieta, J., Moreno‐Rey, C., Hernández, I., Marín, J., Gayán, J., Initiative, A. D. N., González‐Pérez, A., Real, L. M., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.2412 · Cited by 20

Interleukin-1A −889C/T polymorphism and risk of Alzheimer’s disease: a meta-analysis based on 32 case–control studies

Qin, X. Y., Peng, Q., Zeng, Z., Chen, Z., Lin, L., Deng, Y., Huang, X., Xu, J., Wu, H., Huang, S., et al. (2012) · Journal of Neurology · doi:10.1007/s00415-011-6381-6 · Cited by 20

Impact ofPICALMandCLUon hippocampal degeneration

Yang, X., Li, J., Liu, B., Li, Y., & Jiang, T. (2016) · Human Brain Mapping · doi:10.1002/hbm.23183 · Cited by 22

A gene−brain−cognition pathway for the effect of an Alzheimer׳s risk gene on working memory in young adults

Stevens, B. W., DiBattista, A. M., Rebeck, G. W., & Green, A. E. (2014) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2014.06.021 · Cited by 20

Family‐based genome scan for age at onset of late‐onset Alzheimer's disease in whole exome sequencing data

Saad, M., Brkanac, Z., & Wijsman, E. M. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12250 · Cited by 19

Implication of a Genetic Variant at PICALM in Alzheimer's Disease Patients and Centenarians

Piaceri, I., Bagnoli, S., Lucenteforte, E., Mancuso, M., Tedde, A., Siciliano, G., Piacentini, S., Bracco, L., Sorbi, S., & Nacmias, B. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101791 · Cited by 18

Association of aBACE1Gene Polymorphism with Parkinson’s Disease in a Norwegian Population

Lange, J., Lunde, K. A., Sletten, C., Møller, S. G., Tysnes, O., Alves, G. W., Larsen, J. P., & Maple‐Grødem, J. (2015) · Parkinson s Disease · doi:10.1155/2015/973298 · Cited by 18

Association between clusterin gene polymorphism rs11136000 and late-onset Alzheimer's disease susceptibility: A review and meta-analysis of case-control studies

Du, W., Tan, J., Xu, W., Chen, J., & Wang, L. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3734 · Cited by 17

A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer’s Genetic Risk ( CLU + CR1 + PICALM ) Intensifies Cognitive Aging Genetic Risk ( COMT + BDNF ) Selectively for APOE ɛ 4 Carriers

Sapkota, S., & Dixon, R. A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170909 · Cited by 20

Binding between Prion Protein and Aβ Oligomers Contributes to the Pathogenesis of Alzheimer’s Disease

Kong, C., Xie, H., Gao, Z., Shao, M., Li, H., Shi, R., Cai, L., Gao, S., Sun, T., & Li, C. (2019) · Virologica Sinica · doi:10.1007/s12250-019-00124-1 · Cited by 18

Genetic association between clusterin polymorphisms and Alzheimer's disease in a Japanese population

Komatsu, M., Shibata, N., Kuerban, B., Ohnuma, T., Baba, H., & Arai, H. (2011) · Psychogeriatrics · doi:10.1111/j.1479-8301.2010.00346.x · Cited by 17

Single Nucleotide Polymorphism rs11136000 of CLU Gene (Clusterin, ApoJ) and the Risk of Late-Onset Alzheimer’s Disease in a Central European Population

Balcar, V. J., Zeman, T., Janout, V., Janoutová, J., Lochman, J., & Šerý, O. (2021) · Neurochemical Research · doi:10.1007/s11064-020-03176-y · Cited by 17

Association studies of 19 candidate SNPs with sporadic Alzheimer’s disease in the North Chinese Han population

Yuan, Q., Chu, C., & Jia, J. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0881-0 · Cited by 18

Association of MTHFR and PICALM polymorphisms with Alzheimer’s disease

Belcavello, L., Camporez, D., Almeida, L. D., Morelato, R. L., Batitucci, M. C. P., & Paula, F. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3806-1 · Cited by 15

Genetic variants conferring susceptibility to Alzheimer’s disease in the general population; do they also predispose to dementia in Down’s syndrome

Patel, A., Rees, S. D., Kelly, M. A., Bain, S. C., Barnett, A. H., Prasher, A., Arshad, H., & Prasher, V. P. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-42 · Cited by 15

Genetic Complexity of Early-Onset Alzheimer’s Disease

Ghani, M., Reitz, C., George‐Hyslop, P. S., & Rogaeva, E. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-72938-1_3 · Cited by 15

The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum

Xu, W., Wang, H.-F., Tan, L., Tan, M., Tan, C.-C., Zhu, X., Miao, D., Yu, W.-J., Jiang, T., Tan, L., et al. (2016) · Scientific Reports · doi:10.1038/srep24480 · Cited by 14

A novel mouse model expressing human forms for complement receptors CR1 and CR2

Jackson, H. M., Foley, K. E., O’Rourke, R., Stearns, T. M., Fathalla, D., Morgan, B. P., & Howell, G. R. (2020) · BMC Genetics · doi:10.1186/s12863-020-00893-9 · Cited by 14

Extracellular chaperone networks and the export of J-domain proteins

Braun, J. E. A. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102840 · Cited by 15

Evaluation of the global association between cholesterol-associated polymorphisms and Alzheimer's disease suggests a role for rs3846662 and HMGCR splicing in disease risk

Simmons, C. R., Zou, F., Younkin, S. G., & Estus, S. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-62 · Cited by 16

Comorbidity Genes of Alzheimer’s Disease and Type 2 Diabetes Associated with Memory and Cognitive Function

Cho, S. B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042211 · Cited by 12

Linking Protective GAB2 Variants, Increased Cortical GAB2 Expression and Decreased Alzheimer’s Disease Pathology

Zou, F., Belbin, O., Carrasquillo, M. M., Culley, O. J., Hunter, T. A., Ma, L., Bisceglio, G. D., Allen, M., Dickson, D. W., Graff‐Radford, N. R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064802 · Cited by 13

Influence of PICALM and CLU risk variants on beta EEG activity in Alzheimer’s disease patients

Maturana-Candelas, A., Gómez, C., Poza, J., Rodríguez-González, V., Pablo, V. G.-D., Lopes, A. M., Pinto, N., & Hornero, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-99589-y · Cited by 12

Common variant in GAB2 is associated with late-onset Alzheimer's disease in Han Chinese

Zhong, X.-L., Yu, J., Gui-ying, H., Xing, Y.-Y., Jiang, H. F., Li, Y., & Tan, L. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.11.022 · Cited by 12

Blood–Brain Barrier Transport of Alzheimer’s Amyloid β-Peptide

Nelson, A. R., Sagare, A. P., & Zloković, B. V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00009-5 · Cited by 12

Association of LRRTM3 polymorphisms with late-onset Alzheimer's disease in Han Chinese

Wang, J., Yu, J., Jiang, T., Tan, M., Wang, H.-F., Tan, L., Hu, N., Sun, L., Zhang, W., & Tan, L. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.01.013 · Cited by 11

Informative combination of CLU rs11136000, serum HDL levels, diabetes, and age as a new piece of puzzle-picture of predictive medicine for cognitive disorders

Aghajanpour-Mir, M., Amjadi‐Moheb, F., Dadkhah, T., Hosseini, S. R., Ghadami, E., Assadollahi, E., Akhavan‐Niaki, H., & Ahangar, A. A. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4561-5 · Cited by 12

Investigating Statistical Epistasis in Complex Disorders

Turton, J. C., Bullock, J. M., Medway, C., Shi, H., Brown, K. S., Belbin, O., Kalsheker, N. A., Carrasquillo, M. M., Dickson, D. W., Graff‐Radford, N. R., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110197 · Cited by 11

Explore the role of CR1 genetic variants in late-onset Alzheimer’s disease susceptibility

Lu, L., Yao, Q.-Y., Ruan, S.-S., Hu, J.-W., Long, W.-J., Dai, W.-Z., Ma, T., & Zhu, X.-C. (2021) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000291 · Cited by 11

AP180 N-Terminal Homology (ANTH) and Epsin N-Terminal Homology (ENTH) Domains: Physiological Functions and Involvement in Disease

Takatori, S., & Tomita, T. (2018) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_218 · Cited by 10

Optimization of specific multiplex DNA primers to detect variable CLU genomic lesions in patients with Alzheimer’s disease

Giau, V. V., & An, S. S. A. (2015) · BioChip Journal · doi:10.1007/s13206-015-9306-8 · Cited by 10

Association of CLU and TLR2 gene polymorphisms with late-onsetAlzheimer disease in a northwestern Iranian population

Sohrabifar, N., Gharesouran, J., Talebi, M., Ghojazadeh, M., & Ardebili, S. M. M. (2015) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1406-64 · Cited by 9

TrkB Isoforms Differentially Affect AICD Production through Their Intracellular Functional Domains

Ansaloni, S., Leung, B. C. L., Sebastian, N. P., Samudralwar, R. D., Gadaleta, M. C., & Saunders, A. J. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/729382 · Cited by 9

Epigenetic processes in Alzheimer's disease

Castanho, I., & Lunnon, K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813796-3.00008-0 · Cited by 10

GenoRisk: A polygenic risk score for Alzheimer's disease

Dickson, S. P., Hendrix, S. B., Brown, B. L., Ridge, P. G., Nicodemus‐Johnson, J., Hardy, M. L., McKeany, A. M., Booth, S. B., Fortna, R. R., Kauwe, J. S. K., et al. (2021) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12211 · Cited by 8

Autosomal Dominant Alzheimer’s Disease: Underlying Causes

Ghani, M., & Rogaeva, E. A. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6380-0_3 · Cited by 8

Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease

Ma, S. L., & LAM, L. C. W. (2011) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2011.9.2.54 · Cited by 8

Interaction between PPAR γ and SORL1 gene with Late-Onset Alzheimer’s disease in Chinese Han Population

Zhang, H., Zheng, W., Hua, L., Wang, Y., Li, J., Bai, H., Wang, S., Du, M., Ma, X., Xu, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15691 · Cited by 7

Immunity factor contributes to altered brain functional networks in individuals at risk for Alzheimer’s disease: Neuroimaging-genetic evidence

Bai, F., Shi, Y., Yuan, Y., Xie, C., & Zhang, Z. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.02.015 · Cited by 7

Association of Alzheimer’s Disease with Genetic Variants of Apolipoprotein E, Clusterin, TNF-α, and IL-6 Among Elderly Saudis

Abdi, S., Alghamdi, A. A., AlGhunaim, N. N. A., Almutairi, R. M., Ataya, F. S., Ansari, M. G. A., Hussain, S. D., Masoud, M. S., Alamro, A. A., Almutairi, O. T., et al. (2022) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023666220208093919 · Cited by 7

Genetic Association between Alzheimer’s Disease Risk Variant of the PICALM Gene and Auditory Event-Related Potentials in Aging

Пономарева, Н. В., Андреева, Т. В., Протасова, М. А., Filippova, Y. V., Kolesnikova, E. P., Fokin, V. F., Illarioshkin, S. N., & Rogaev, E. I. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918090092 · Cited by 6

Correction: Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease

Jones, L., Holmans, P., Hamshere, M. L., Harold, D. H., Moskvina, V., Ivanov, D. K., Pocklington, A. J., Abraham, R., Hollingworth, P., Sims, R., et al. (2011) · PLoS ONE · doi:10.1371/annotation/a0bb886d-d345-4a20-a82e-adce9b047798 · Cited by 6

Dementia key gene identification with multi-layered SNP-gene-disease network

Lee, D. A., Kim, M.-J., Son, S. J., Hong, C. H., & Shin, H. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa814 · Cited by 5

The Implications of Genomics on the Nursing Care of Adults With Neuropsychiatric Conditions

Schutte, D. L., Davies, M. A., & Goris, E. D. (2013) · Journal of Nursing Scholarship · doi:10.1111/jnu.12006 · Cited by 5

From Molecule to Clinic and Community for Neurodegeneration: Research to Bridge Translational Gaps

Brayne, C., Barker, R. A., Harold, D. H., Ince, P. G., Savva, G. M., Williams, J. H., Williams‐Gray, C. H., & Wharton, S. B. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129006 · Cited by 5

Rheumatoid arthritis-associated polymorphisms are not protective against Alzheimer's disease

Simmons, C. R., Zou, F., Younkin, S. G., & Estus, S. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-33 · Cited by 5

Genetic variant rs11136000 upregulates clusterin expression and reduces Alzheimer’s disease risk

Ma, J., & Qiu, S. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.926830 · Cited by 5

Meta-analysis of association between the genetic polymorphisms on chromosome 11q and Alzheimer's disease susceptibility.

Ji, W., Xu, L., Zhou, H., Wang, S., & Fang, Y. (2015) · PubMed · Cited by 5

Genetics of A lzheimer's Disease

Brookes, K. J., & Morgan, K. (2017) · Wiley eBooks · doi:10.1002/9780470015902.a0020228.pub2 · Cited by 6

The role of amyloid beta 4-42 in the etiology of Alzheimer's disease

Bouter, Y. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4849 · Cited by 5

Link of BIN1, CLU, and fIDE Gene Polymorphisms with the Susceptibility of Alzheimer’s Disease: Evidence from a Meta-analysis

Aziz, M. A., Ashraf, G. M., & Islam, M. S. (2022) · Current Alzheimer Research · doi:10.2174/1567205019666220511140955 · Cited by 4

Genetic Risk Factors for Dementia

Hollingworth, P., & Williams, J. H. (2011) · Wiley eBooks · doi:10.1002/9781444344110.ch6 · Cited by 4

Correlation of PICALM polymorphism rs3851179 with Alzheimer’s disease among Caucasian and Chinese populations: a meta-analysis and systematic review

Zhu, B., Li, L., Zhang, L., Yang, S., Tian, Y., Guo, S., Zhang, W., & Zhao, Z. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0291-6 · Cited by 2

The Role of the Progesterone Receptor Family in Alzheimer’s Disease

Zhu, T., & Hua, F. (2025) · Biocell · doi:10.32604/biocell.2025.064879 · Cited by 1

Genetic Risk Factors: Their Function and Comorbidities in Alzheimer′s Disease

Hiltunen, M. O., Bertram, L., & Saunders, A. J. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/925362 · Cited by 1

P1‐219: Polymorphisms of CR1, CLU and PICALM Confer Susceptibility of Alzheimer's Disease in Southern Chinese Population

Chen, L. H., Kao, P. Y. P., Fan, Y., Ho, D. T. Y., Chan, S. Y., Yik, P. Y., Ha, J. C. T., Chu, L., & Song, Y. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.498 · Cited by 1

Complement Component (3b/4b) Receptor 1 (CR1)

Lord, J., & Morgan, K. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7309-1_5 · Cited by 1

The beginnings of Alzheimer’s disease: A review on inflammatory, mitochondrial, genetic and epigenetic pathways

Perna, S., Bologna, C., Cavagna, P., Bernardinelli, L., Guido, D., Peroni, G., & Rondanelli, M. (2016) · Genetika · doi:10.2298/gensr1602515p · Cited by 1

Pharmacogenomics and Personalized Medicine in Alzheimer’s Disease

Archer, T., & Johansson, B. E. A. (2013) · Springer eBooks · doi:10.1007/978-81-322-1184-6_15 · Cited by 1

Clusterin

Lord, J., & Morgan, K. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7309-1_3 · Cited by 1

Sex effects in predictors of memory resilience for carriers of Alzheimer’s genetic risk

McDermott, K. L. (2016) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3st7f49f · Cited by 1

Clusterin, TNF-α, and IL-6 polymorphism and implications on Alzheimer’s disease risk determination in Saudi populationPreprint

Algamdi, A. A., Abdi, S., Almutairi, R. M., Sarwar, S., Aldaghri, N., Haq, S. H., Alamro, A. A., & Muayqil, T. A. (2021) · Research Square · doi:10.21203/rs.3.rs-287829/v1 · Cited by 1

Alzheimer’s Disease Genomics and Clinical Applications

Lee, T.-S. W., & Sian, M. (2011) · InTech eBooks · doi:10.5772/18773

GENOME-WIDE ASSOCIATION STUDIES AT THE INTERFACE OF ALZHEIMER'S DISEASE AND EPIDEMIOLOGICALLY RELATED DISORDERS

Simmons, C. R. (2011) · UKnowledge (University of Kentucky)

Further insights into Alzheimer's disease

Sims, R., Gerrish, A., & Williams, J. H. (2012) · Quality in Ageing and Older Adults · doi:10.1108/14717791211264043

P2‐030: INVESTIGATING THE ROLE OF CLU, PICALM, AND CR1 IN ALZHEIMER'S DISEASE

Lord, J., Turton, J. C., Braae, A., Barber, I., Medway, C., Brown, K. S., & Morgan, K. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.05.703

Genetica delle demenze degenerative

Wallon, D., & Nicolas, G. (2015) · EMC - Neurologia · doi:10.1016/s1634-7072(15)73962-0

The role of Kat2a during memory formation and chromatin plasticity in the aging murine hippocampus

Stilling, R. M. (2013) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3945

Characterising the role of CR1 and CR2 in a humanised mouse model

Williams, H. M. (2016) · ORCA Online Research @Cardiff (Cardiff University)

Screening and evaluation of natural compounds for therapeutic application in Alzheimer's disease

Nirvanashetty, S. (2024) · Swinburne figshare (Swinburne University of Technology) · doi:10.25916/sut.26278636

Genomika obrazowa: nowy trend w badaniach nad chorobą Alzheimera

Dzianok, P. (2020) · Kosmos · doi:10.36921/kos.2020_2636

Association of CLU and PICALM variants with Alzheimer's disease

Kamboh, M. I., Minster, R. L., Demirci, F. Y., Ganguli, M., DeKosky, S. T., López, O. L., & Barmada, M. M. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.015 · Cited by 77

Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals

Corneveaux, J. J., Myers, A. J., Allen, A. N., Pruzin, J. J., Ramirez, M., Engel, A., Nalls, M. A., Chen, K., Lee, W., Chewning, K., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq221 · Cited by 237

Polymorphisms of CR1, CLU and PICALM confer susceptibility of Alzheimer's disease in a southern Chinese population

Chen, L. H., Kao, P. Y. P., Fan, Y., Ho, D. T. Y., Chan, C. S. Y., Yik, P. Y., Ha, J. C. T., Chu, L., & Song, Y. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.016 · Cited by 89

Implication of common and disease specific variants in CLU, CR1, and PICALM

Ferrari, R., Moreno, J. H., Minhajuddin, A., O’Bryant, S. E., Reisch, J., Barber, R. C., & Momeni, P. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.01.110 · Cited by 49

Questions No 10-2012

(2012) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2012.10.022